CSIMarket
 


Vyant Bio Inc   (VYNT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Vyant Bio Inc 's Tangible Leverage Ratio

VYNT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


Due to repayements of liabilities of -42.43% Vyant Bio Inc improved Tangible Leverage Ratio in forth quarter 2022 to 0.53, below the company's average Tangible Leverage Ratio.

Within Medical Laboratories industry in the forth quarter 2022, 22 other companies have achieved lower Tangible Leverage Ratio than Vyant Bio Inc in the IV Quarter 2022. While Tangible Leverage Ratio total ranking has deteriorated compared to the third quarter 2022 from 1405 to 1409 .

Explain Tangible Leverage Ratio?
What is VYNT Market Share?
What are VYNT´s Total Liabilities?


VYNT Tangible Leverage Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Tangible Equity Change -68.33 % -44.21 % -42.31 % -30.59 % 3019.64 %
Y / Y Total Liabilities Change -16.55 % 73.44 % 87.79 % 20.01 % 45.28 %
Tangible Leverage Ratio MRQ 0.53 0.66 0.6 0.45 0.2
VYNT's Total Ranking # 1409 # 1405 # 1428 # 1220 # 1422
Seq. Tangible Equity Change -28.4 % -17.56 % -24.95 % -28.51 % 26.14 %
Seq. Total Liabilities Change -42.43 % -8.23 % -1.35 % 60.12 % 19.65 %



Tangible Leverage Ratio forth quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 566
Overall Market # 1409


Tangible Leverage Ratio Statistics
High Average Low
6.51 1.12 0.09
(Jun 30 2019)   (Jun 30 2021)




Financial Statements
Vyant Bio Inc 's Tangible Equity $ 10 Millions Visit VYNT's Balance sheet
Vyant Bio Inc 's Total Liabilities $ 5 Millions Visit VYNT's Balance sheet
Source of VYNT's Sales Visit VYNT's Sales by Geography


Cumulative Vyant Bio Inc 's Tangible Leverage Ratio

VYNT's Tangible Leverage Ratio for the trailling 12 Months

VYNT Tangible Leverage Ratio

(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Tangible Equity TTM Growth -68.33 % -44.21 % -42.31 % -30.59 % 3019.64 %
Y / Y Total Liabilities TTM Growth -16.55 % 73.44 % 87.79 % 20.01 % 45.28 %
Tangible Leverage Ratio TTM 0.55 0.42 0.33 0.25 0.22
Total Ranking TTM # 1342 # 961 # 667 # 4 # 271
Seq. Tangible Equity TTM Growth -28.4 % -17.56 % -24.95 % -28.51 % 26.14 %
Seq. Total Liabilities TTM Growth -42.43 % -8.23 % -1.35 % 60.12 % 19.65 %


On the trailing twelve months basis Despite of the repayements of liabilities of -42.43% in the trailing twelve months ending in IV Quarter 2022, Tangible Leverage Ratio improved to 0.55, below Vyant Bio Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry 20, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Vyant Bio Inc . While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the IV Quarter 2022, compared to the prior period, from 961 to 1342.

Explain Tangible Leverage Ratio?
What is VYNT Market Share?
What are VYNT´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 21
Healthcare Sector # 564
Within the Market # 1342


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
4.26 1.07 0.12
(Jun 30 2019)   (Dec 31 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Dec 31 2022, within Medical Laboratories Industry Tangible Leverage RatioDec 31 2022 MRQ Total LiabilitiesDec 31 2022 MRQ Tangible Equity
Exagen Inc   1.01 $ 42.721  Millions$ 42.460  Millions
Natera inc   0.96 $ 677.953  Millions$ 705.744  Millions
American Shared Hospital Services  0.92 $ 22.331  Millions$ 24.282  Millions
Genetron Holdings Ltd  0.78 $ 61.905  Millions$ 79.504  Millions
Omniab Inc   0.77 $ 69.852  Millions$ 90.152  Millions
Aclarion Inc   0.68 $ 0.689  Millions$ 1.016  Millions
Psychemedics Corp  0.64 $ 6.924  Millions$ 10.771  Millions
Vyant Bio Inc   0.53 $ 5.296  Millions$ 9.909  Millions
Dermtech Inc   0.53 $ 69.722  Millions$ 132.353  Millions
Veracyte inc   0.36 $ 74.539  Millions$ 204.443  Millions
Incyte Corporation  0.36 $ 1,467.686  Millions$ 4,085.307  Millions
Personalis Inc   0.34 $ 74.561  Millions$ 218.139  Millions
Burning Rock Biotech Limited  0.33 $ 54.593  Millions$ 167.656  Millions
Caredx Inc   0.32 $ 112.080  Millions$ 350.337  Millions
Celcuity Inc   0.31 $ 41.926  Millions$ 133.771  Millions
Bionexus Gene Lab Corp   0.31 $ 2.059  Millions$ 6.665  Millions
Butterfly Network inc   0.28 $ 92.210  Millions$ 325.360  Millions
Nano x Imaging Ltd  0.25 $ 29.436  Millions$ 118.041  Millions
Ispecimen inc   0.21 $ 4.308  Millions$ 20.309  Millions
Sera Prognostics Inc   0.18 $ 17.386  Millions$ 98.943  Millions
Absci Corp  0.17 $ 33.858  Millions$ 201.457  Millions
Somalogic Inc   0.16 $ 84.816  Millions$ 535.459  Millions
Castle Biosciences Inc   0.13 $ 36.218  Millions$ 272.802  Millions
Fulgent Genetics Inc   0.12 $ 119.368  Millions$ 976.205  Millions

Date modified: 2023-04-24T20:08:15+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com